DE2366394C1 - 4H-Benzo [4,5] cyclohepta [1,2-b] thiophene-4-one and its preparation - Google Patents
4H-Benzo [4,5] cyclohepta [1,2-b] thiophene-4-one and its preparationInfo
- Publication number
- DE2366394C1 DE2366394C1 DE2366394A DE2366394A DE2366394C1 DE 2366394 C1 DE2366394 C1 DE 2366394C1 DE 2366394 A DE2366394 A DE 2366394A DE 2366394 A DE2366394 A DE 2366394A DE 2366394 C1 DE2366394 C1 DE 2366394C1
- Authority
- DE
- Germany
- Prior art keywords
- benzo
- cyclohepta
- thiophen
- general formula
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/78—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/78—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings
- C07D333/80—Seven-membered rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Hydrogenated Pyridines (AREA)
Description
in der R1 Wasserstoff oder einen in 6- oder 7-Stellung ständigen Halogen- oder niederen Alkoxyrest bedeutet und R2 für niederes Alkyl steht.in which R 1 is hydrogen or a halogen or lower alkoxy radical in the 6- or 7-position and R 2 is lower alkyl.
2. Verfahren zur Herstellung der Verbindungen nach Anspruch 1 dadurch gekennzeichnet, daß man Verbindungen der allgemeinen Formel III,2. Process for the preparation of the compounds according to claim 1, characterized in that one Compounds of the general formula III,
fflffl
in der R1 die im Anspruch 1 angegebene Bedeutung besitzt und X für Chlor oder Brom steht, mit Alkanolen der allgemeinen Formel IV,in which R 1 has the meaning given in claim 1 and X is chlorine or bromine, with alkanols of the general formula IV,
R2OH IVR 2 OH IV
in der R2 die im Anspruch 1 angegebene Bedeutung besitzt, umsetzt und die erhaltenen Verbindungen der allgemeinen Formel II,in which R 2 has the meaning given in claim 1, reacts and the compounds of the general formula II obtained,
OR2 OR 2
in der R1, R1 und X die angegebenen Bedeutungen besitzen, einer HX-Abspaltung in an sich bekannter Weise unterwirft.in which R 1 , R 1 and X have the meanings given, subjected to an HX elimination in a manner known per se.
Die Erfindung betrifft Verbindungen der allgemeinen Formel I,The invention relates to compounds of the general formula I,
OR-OR-
in der R1 die angegebene Bedeutung besitzt und X für Chlor oder Brom steht, mit Alkanolen der allgemeinen Formel IV,in which R 1 has the meaning given and X stands for chlorine or bromine, with alkanols of the general formula IV,
R2OHR 2 OH
in der R2 die angegebene Bedeutung besitzt, umsetzt und die erhaltenen Verbindungen der allgemeinen Formel II,in which R 2 has the meaning given, reacts and the compounds of the general formula II obtained,
OR2 OR 2
in der R', R2 und X die angegebene Bedeutung besitzen, einer HX-Abspaltung in an sich bekannter Weise unterwirft. in which R ', R 2 and X have the meaning given, subjected to an HX elimination in a manner known per se.
so Die Umsetzung erfolgt zweckmäßig unter Erwärmen, vorzugsweise unter Rückflußtemperatur. Die Zugabe von Silbernitrat, z. B. etwa 1 Mol bezogen auf 1 Mol Verbindung der allgemeinen Formel III, beschleunigt die Reaktion und erlaubt eine Umsetzung bei niedriger Temperatür, z. B. bei Raumtemperatur. Bei der Umsetzung entstehen als einheitliches Reaktionsprodukt Verbindungen der allgemeinen Formel II: Die Äthergruppe wird überraschenderweise praktisch quantitativ in ΙΟ-Stellung des Tricyclus eingeführt.The reaction is expediently carried out with heating, preferably under reflux temperature. The addition of Silver nitrate, e.g. B. about 1 mole based on 1 mole of the compound of general formula III, accelerates the reaction and allows implementation at a low temperature, e.g. B. at room temperature. During the implementation arise as a uniform reaction product compounds of the general formula II: The ether group is surprisingly introduced practically quantitatively in the ΙΟ-position of the tricycle.
Die Säure HX wird unter alkalischen Bedingungen abgespalten, beispielsweise durch Behandlung der Verbindungen der allgemeinen Formel II mit einer Lösung von Kaliumhydroxid in einem unter den herrschenden Bedingungen inerten organischen Lösungsmittel, wie Methanol.The acid HX is split off under alkaline conditions, for example by treating the compounds of the general formula II with a solution of potassium hydroxide in one of the prevailing Conditions of inert organic solvents such as methanol.
Die Verbindungen der allgemeinen Formel I stellen wertvolle Zwischenprodukte dar. Sie können zur Herstellung pharmakologisch wirksamer Verbindungen, z. B.The compounds of general formula I are valuable intermediates. They can be used for the preparation pharmacologically active compounds, e.g. B.
von 4-Piperidyliden-4H-benzo[4,5]cyclohepta[l ,2-b]of 4-piperidylidene-4H-benzo [4,5] cyclohepta [l, 2-b]
thiophen-I0(9H)-onen, verwendet werden.thiophene-I0 (9H) -ones can be used.
10-Methoxy4H-benzo[4,5]cyclohepta[l,2-b]
thiophen-4-on10-methoxy4H-benzo [4,5] cyclohepta [1,2-b]
thiophen-4-one
a) 9-Brom-9,10-dihydro-10-methoxy-4H-benzo[4,5] cycIohepta[l,2-b]thiophen-4-on (Verbindung der Formel II)a) 9-Bromo-9,10-dihydro-10-methoxy-4H-benzo [4,5] cyclohepta [1,2-b] thiophen-4-one (compound of Formula II)
1010
Eine Suspension von 20 g 9,10-Dibrom-9,I0-dihydro-4H-benzo[4,5]cyclohepta[l,2-b]thiophen-4-on in 400 cm3 Methanol wird 5 Stunden unter Rückfluß gekocht. Man erhält 9-Brom-9,10-dihydro-10-methoxy-4H-benzo[4,5] cyclohepta[l,2-b]thiophen-4-on (F. 103 bis 106° C).A suspension of 20 g of 9,10-dibromo-9,10-dihydro-4H-benzo [4,5] cyclohepta [1,2-b] thiophen-4-one in 400 cm 3 of methanol is refluxed for 5 hours. 9-Bromo-9,10-dihydro-10-methoxy-4H-benzo [4,5] cyclohepta [1,2-b] thiophen-4-one (melting point 103 to 106 ° C.) is obtained.
b) 10-methoxy-4H-benzo[4,5]cyclohepta[l ,2-b] thiophen-4-onb) 10-methoxy-4H-benzo [4,5] cyclohepta [1,2-b] thiophen-4-one
Zu einer Lösung von 17,5 g 9-Brom-9,10-dihydro-10-methoxy^H-benzo^^lcycloheptatl^-blthiophen^-on in 400 cm3 Methanol werden 9 g Kaliumhydroxid gegeben und die Lösung 6 Stunden unter Rückfluß gekocht. Nach dem Abkühlen auf 0 bis 5° C wird das ausgefallene Kristallisat abfiltriert und aus Methanol umkristallisiert. Auf diese Weise wird das reine 10-Methoxy-4H-benzo[4,5]cyclohepta[l,2-b]thiophen-4-on erhalten, welches bei 164 bis 166° C schmilzt. Die Mikroanalyse stimmt auf die Formel C14H10O2S. Die Struktur wurde mit Hilfe der NMR- und MS-Spektren ermittelt.To a solution of 17.5 g of 9-bromo-9,10-dihydro-10-methoxy ^ H-benzo ^^ lcycloheptatl ^ -blthiophen ^ -one in 400 cm 3 of methanol, 9 g of potassium hydroxide are added and the solution under Refluxed. After cooling to 0 to 5 ° C., the precipitated crystals are filtered off and recrystallized from methanol. In this way the pure 10-methoxy-4H-benzo [4,5] cyclohepta [1,2-b] thiophen-4-one, which melts at 164 to 166 ° C., is obtained. The microanalysis agrees with the formula C 14 H 10 O 2 S. The structure was determined with the aid of the NMR and MS spectra.
Analog Beispiel 1 und unter Verwendung folgender Verbindungen der Formel IIAnalogously to Example 1 and using the following compounds of the formula II
- 9-Brom-6-chlor-9,10-dihydro-10-methoxy-4H-benzo [4,5]cyclohepta[l,2-b]thiophen-4-on(F. 134 bis 136° C),- 9-Bromo-6-chloro-9,10-dihydro-10-methoxy-4H-benzo [4,5] cyclohepta [1,2-b] thiophen-4-one (melting point 134 to 136 ° C),
- 9-Brom-7-chlor-9,10-dihydro-10-methoxy-4H-benzo [4,5]cyclohepta[l,2-b]thiophen-4-on (F. 135 bis 137° C),- 9-Bromo-7-chloro-9,10-dihydro-10-methoxy-4H-benzo [4,5] cyclohepta [1,2-b] thiophen-4-one (melting point 135 to 137 ° C),
- 6,9-Dibrom-9,10-dihydro-10-methoxy-4H-benzo[4,5] cyclohepta[ 1,2-b]thiophen-4-on,- 6,9-dibromo-9,10-dihydro-10-methoxy-4H-benzo [4,5] cyclohepta [1,2-b] thiophen-4-one,
- 9-Brom-9,10-dihydro-7,10-dimethoxy-4H-benzo[4,5] cyclohepta[l ,2-b]thiophen-4-on,- 9-Bromo-9,10-dihydro-7,10-dimethoxy-4H-benzo [4,5] cyclohepta [1,2-b] thiophen-4-one,
- 9-Brom-10-butoxy-9,10-dihydro-4H-benzo[4,5] cyclohepta[l,2-b]thiophen-4-on (F. 90 bis 9Γ C) und- 9-Bromo-10-butoxy-9,10-dihydro-4H-benzo [4,5] cyclohepta [1,2-b] thiophen-4-one (m.p. 90 to 9Γ C) and
- 9-Brom-10-äthoxy-9,10-dihydro-4H-benzo[4,5] cycloheptaD ,2-b]thiophen-4-on- 9-Bromo-10-ethoxy-9,10-dihydro-4H-benzo [4,5] cycloheptaD, 2-b] thiophen-4-one
gelangt man zu folgenden Verbindungen der Formel I:the following compounds of the formula I are obtained:
- 6-ChIor-l0-methoxy-4H-benzo[4,5]cyclohepta[l ,2-b] thiophen-4-on (F. 220 bis 222° C),- 6-chloro-10-methoxy-4H-benzo [4,5] cyclohepta [1,2-b] thiophen-4-one (m.p. 220 to 222 ° C),
- 7-Chlor-10-methoxy-4H-benzo[4,5]cyclohepta[!,2-b] thiophen-4-on (F. 216 bis 218° C),- 7-chloro-10-methoxy-4H-benzo [4,5] cyclohepta [!, 2-b] thiophen-4-one (melting point 216 to 218 ° C),
- 6-Brom-10-methoxy-4H-benzo[4,5]cyclohepta[l,2-b] thiophen-4-on,- 6-Bromo-10-methoxy-4H-benzo [4,5] cyclohepta [1,2-b] thiophen-4-one,
- 7,10-Dimethoxy-4H-benzo[4,5]cyclohepta[l ,2-b] thiophen-4-on (F. 83 bis 85° C),- 7,10-Dimethoxy-4H-benzo [4,5] cyclohepta [1,2-b] thiophen-4-one (melting point 83 to 85 ° C),
- 10-Butoxy-4H-benzo[4,5]cyc!ohepta[l,2-b] thiophen-4-on (F. 83 bis 85° C) und- 10-Butoxy-4H-benzo [4,5] cyc! Ohepta [1,2-b] thiophen-4-one (mp 83 to 85 ° C) and
- 10-Äthoxy-4H-benzo[4,5]cyclohepta[l ,2-b] thiophen-4-on (F. 127 bis 129° C).- 10-Ethoxy-4H-benzo [4,5] cyclohepta [1,2-b] thiophen-4-one (m.p. 127-129 ° C).
- Leerseite -- blank page -
Claims (1)
der allgemeinen Formel I,1. 4H-Benzo [4,5] cydohepta [1,2-b] thiophen-4-ones
of the general formula I,
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH98572A CH568312A5 (en) | 1972-01-24 | 1972-01-24 |
Publications (1)
Publication Number | Publication Date |
---|---|
DE2366394C1 true DE2366394C1 (en) | 1983-01-20 |
Family
ID=4199789
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE2302970A Expired DE2302970C3 (en) | 1972-01-24 | 1973-01-22 | Process for the preparation of 4- (1-substituted-4-piperidylidene) -4H-benzo [4,5] cyclohepta [1,2-b] thiophene-10 (9H) -ones |
DE2366394A Expired DE2366394C1 (en) | 1972-01-24 | 1973-01-22 | 4H-Benzo [4,5] cyclohepta [1,2-b] thiophene-4-one and its preparation |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE2302970A Expired DE2302970C3 (en) | 1972-01-24 | 1973-01-22 | Process for the preparation of 4- (1-substituted-4-piperidylidene) -4H-benzo [4,5] cyclohepta [1,2-b] thiophene-10 (9H) -ones |
Country Status (29)
Country | Link |
---|---|
JP (2) | JPS566997B2 (en) |
KR (1) | KR780000049B1 (en) |
AR (1) | AR202094A1 (en) |
AT (1) | AT334897B (en) |
AU (1) | AU477308B2 (en) |
BE (1) | BE794370A (en) |
CA (1) | CA1006523A (en) |
CH (1) | CH568312A5 (en) |
CS (1) | CS183674B2 (en) |
DD (1) | DD104084A5 (en) |
DE (2) | DE2302970C3 (en) |
DK (2) | DK154296C (en) |
ES (1) | ES410855A1 (en) |
FI (1) | FI60396C (en) |
FR (2) | FR2169091B1 (en) |
GB (2) | GB1422443A (en) |
HK (1) | HK53480A (en) |
HU (1) | HU164966B (en) |
IE (1) | IE38148B1 (en) |
IL (1) | IL41374A (en) |
LU (1) | LU66876A1 (en) |
NL (1) | NL178970C (en) |
NO (1) | NO136978C (en) |
PL (1) | PL83921B1 (en) |
RO (1) | RO63566A (en) |
SE (1) | SE395696B (en) |
SU (1) | SU509237A3 (en) |
YU (1) | YU36173B (en) |
ZA (1) | ZA73494B (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8377967B2 (en) | 2008-01-30 | 2013-02-19 | Nippon Zoki Pharmaceutical Co., Ltd. | Piperidine derivative |
TWI457341B (en) * | 2008-08-01 | 2014-10-21 | Nippon Zoki Pharmaceutical Co | Aminopropyl derivative |
JP5083989B2 (en) * | 2008-11-20 | 2012-11-28 | 日本臓器製薬株式会社 | Medicaments containing piperidine derivatives |
CN104817532B (en) * | 2015-03-04 | 2017-07-25 | 浙江工业大学 | A kind of preparation method of the ketone of 10 methoxyl group 4H benzos [4,5] cycloheptatriene [1,2 b] thiazole 4 |
-
1972
- 1972-01-24 CH CH98572A patent/CH568312A5/xx not_active IP Right Cessation
-
1973
- 1973-01-12 FI FI89/73A patent/FI60396C/en active
- 1973-01-15 SE SE7300504A patent/SE395696B/en unknown
- 1973-01-16 NO NO185/73A patent/NO136978C/en unknown
- 1973-01-19 NL NLAANVRAGE7300797,A patent/NL178970C/en not_active IP Right Cessation
- 1973-01-19 FR FR7301856A patent/FR2169091B1/fr not_active Expired
- 1973-01-22 IE IE90/73A patent/IE38148B1/en unknown
- 1973-01-22 GB GB311973A patent/GB1422443A/en not_active Expired
- 1973-01-22 DE DE2302970A patent/DE2302970C3/en not_active Expired
- 1973-01-22 AT AT47873*#A patent/AT334897B/en not_active IP Right Cessation
- 1973-01-22 BE BE794370D patent/BE794370A/en not_active IP Right Cessation
- 1973-01-22 DD DD168384A patent/DD104084A5/xx unknown
- 1973-01-22 DE DE2366394A patent/DE2366394C1/en not_active Expired
- 1973-01-22 PL PL1973160372A patent/PL83921B1/pl unknown
- 1973-01-22 LU LU66876A patent/LU66876A1/xx unknown
- 1973-01-22 KR KR7300110A patent/KR780000049B1/en active
- 1973-01-22 CA CA161,801A patent/CA1006523A/en not_active Expired
- 1973-01-22 RO RO7300073573A patent/RO63566A/en unknown
- 1973-01-22 HU HUSA2446A patent/HU164966B/hu unknown
- 1973-01-22 GB GB2921475A patent/GB1422444A/en not_active Expired
- 1973-01-22 ES ES410855A patent/ES410855A1/en not_active Expired
- 1973-01-23 AU AU51378/73A patent/AU477308B2/en not_active Expired
- 1973-01-23 SU SU1874878A patent/SU509237A3/en active
- 1973-01-23 CS CS7300000503A patent/CS183674B2/en unknown
- 1973-01-23 ZA ZA730494A patent/ZA73494B/en unknown
- 1973-01-23 IL IL41374A patent/IL41374A/en unknown
- 1973-01-23 JP JP922773A patent/JPS566997B2/ja not_active Expired
- 1973-01-27 AR AR246230A patent/AR202094A1/en active
- 1973-04-22 YU YU178/73A patent/YU36173B/en unknown
-
1978
- 1978-10-04 FR FR7828336A patent/FR2401153A1/en active Granted
-
1980
- 1980-02-29 JP JP2420780A patent/JPS55129282A/en active Granted
- 1980-09-25 HK HK534/80A patent/HK53480A/en unknown
- 1980-12-29 DK DK555680A patent/DK154296C/en not_active IP Right Cessation
-
1990
- 1990-10-02 DK DK238090A patent/DK161324C/en not_active IP Right Cessation
Non-Patent Citations (1)
Title |
---|
NICHTS-ERMITTELT * |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69206745T2 (en) | PRODUCTION OF NEOPENTYL GLYCOL | |
DE2366394C1 (en) | 4H-Benzo [4,5] cyclohepta [1,2-b] thiophene-4-one and its preparation | |
DE1670306A1 (en) | Process for the preparation of 5-phenyl-1H-1,5-benzodiazepine-2,4-diones | |
DE68920298T2 (en) | Process for the preparation of 4-acetoxyazetidinones. | |
DE1288086B (en) | ||
DE2642608A1 (en) | 4-HYDROXYMETHYL-2-PYRROLIDINONE AND THE METHOD FOR THEIR PRODUCTION | |
AT259562B (en) | Process for the preparation of benzodiazepine derivatives | |
DE1218453B (en) | Process for the preparation of 5,5'-dialkyl-10,10'-spiro-bis-phenaza compounds | |
DE573190C (en) | Process for the preparation of derivatives of alpha-alpha-alpha-tribromoethane | |
AT257617B (en) | Process for the preparation of benzodiazepine derivatives | |
DE3735862C2 (en) | ||
DE1643322A1 (en) | Azidozimtaldehydes and process for their preparation | |
DE1793711B2 (en) | Process for the preparation of an unsaturated aldehyde | |
DE1211181B (en) | Process for the preparation of azulenes substituted in the 1- and / or 3-position | |
AT210428B (en) | Process for the preparation of new pyrido-benzothiazine derivatives substituted with a monovalent sulfur function | |
AT215430B (en) | Process for the production of new ferrocene derivatives | |
AT262294B (en) | Process for the preparation of benzodiazepine derivatives and the corresponding 4-deoxy compounds and salts | |
AT318154B (en) | METHOD OF MANUFACTURING NEW STEROIDS | |
AT272337B (en) | Process for the preparation of new 5-nitroimidazole derivatives | |
AT219616B (en) | Process for the production of dibenzyltin dichloride or dibenzyltin dichlorides substituted in the benzene nucleus | |
DE2356999A1 (en) | 1,2-DIHYDROINDENE-2-SPIRO-2'-PIPERAZINE DERIVATIVES AND THE METHOD FOR THEIR PRODUCTION | |
DE2113254C3 (en) | Process for the preparation of γ-piperidinoburyrophenone derivatives | |
DD272854A1 (en) | METHOD FOR PRODUCING 3 BETA-SUBSTITUTED (20S) -20-ARYL-SULFONYLMETHYL-PREGNA-5,7-DIENES | |
DE2615706C2 (en) | Process for the preparation of o- (N-monosubstituted-amino) -benzyl alcohols | |
DE2163029C3 (en) | 4-Substituted 1-Oxide-6,7-methylenedioxy-3-quinolinecarboxylic acid derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AC | Divided out of |
Ref country code: DE Ref document number: 2302970 Format of ref document f/p: P |
|
8100 | Publication of patent without earlier publication of application | ||
AC | Divided out of |
Ref country code: DE Ref document number: 2302970 Format of ref document f/p: P |
|
D1 | Grant (no unexamined application published) patent law 81 | ||
8364 | No opposition during term of opposition |